Gregory Sessler

Gregory Sessler

Corporate Officer/Principal bij
Washington Biotechnology & Biomedical Association
73 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Gregory Sessler is a member of The American Institute of Certified Public Accountants, Financial Executives International, and the Washington Biotechnology & Biomedical Association.
He previously held positions as Co-Chairman at Adhera Therapeutics, Inc., Director at MDRNA, Inc., and Chief Financial Officer at Microprobe Corp., Sonus Pharmaceuticals, Inc., and Rosetta Inpharmatics LLC.
He also served as President, Chief Financial & Operating Officer at Spiration, Inc. and Senior Vice President-Technology Development at Gyrus ACMI, Inc. Currently, he is an Independent Director at Impinj, Inc. Mr. Sessler received his undergraduate degree from Syracuse University and his MBA from Stanford Graduate School of Business.

Actieve functies van Gregory Sessler

BedrijvenFunctieBegin
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Eerdere bekende functies van Gregory Sessler

BedrijvenFunctieEinde
IMPINJ, INC. Directeur/Bestuurslid 08-06-2023
Hoofd Techniek/Wetenschap/O&O 01-12-2021
ADHERA THERAPEUTICS, INC. Voorzitter 22-08-2012
Directeur/Bestuurslid 22-07-2010
Financieel Directeur/CFO 01-07-2001
Ervaring van Gregory Sessler in detail bekijken

Opleiding van Gregory Sessler

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

56

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit15

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Electronic Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Gregory Sessler
-40 %: de beste tools exclusief voor abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU